Table 3. Associations of various clinicopathological factors with EPAS1 rs13419896 polymorphism in NSCLC patients.
| rs13419896 | ||||
|---|---|---|---|---|
| G/G | A/G or A/A | P | ||
| Mean Age (yr) | 65.0 | 66.6 | 0.41 | |
| (SD) | 7.7 | 8.6 | ||
| Gender (n) | Male (%) | 31 (40.8) | 25 (32.9) | 0.07 |
| Female (%) | 6 (7.9) | 14 (18.4) | ||
| Histology (n) | Adenocarcinoma (%) | 20 (26.3) | 23 (30.3) | 0.93 |
| Adenosquamous Carcinoma (%) | 2 (2.6) | 2 (2.6) | ||
| Squamous Cell Carcinoma (%) | 15 (19.8) | 14 (18.4) | ||
| Stage (n) | I (%) | 16 (21.1) | 15 (19.7) | 0.13 |
| II (%) | 6 (7.9) | 1 (1.3) | ||
| III (%) | 11 (14.5) | 14 (18.4) | ||
| IV (%) | 4 (5.3) | 9 (11.8) | ||
| Differentiation (n) | Well (%) | 5 (6.6) | 13 (17.1) | 0.06 |
| Moderately (%) | 16 (21.0) | 19 (25.0) | ||
| Poorly (%) | 13 (17.1) | 6 (7.9) | ||
| NA b (%) | 3 (4.0) | 1 (1.3) | ||
| Mean tumor size a (cm) | 3.9 | 4.4 | 0.20 | |
| (SD) | 1.5 | 1.7 | ||
aTwo cases were missing for the data of tumor size.
bNA, not applicable.